drugset / Trial / NCT02713061
A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants
NaSingle-groupOpen-labelTreatment
Summary
This clinical trial is a Phase 2 study of a single subcutaneous injection of TAK-850 for 22 days in healthy Japanese adults.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-850 | Vaccine | 0.5 ml | Subcutaneous |
Indications
No indication recorded.